Introduction

Established in 1997, and incorporated in 2011, Zhejiang Starry Pharmaceutical Co., Ltd, is a vertically integrated high-technology pharmaceutical manufacturer in China.

Starry Pharmaceutical is the leading API manufacuturer of X-CT non-ionic contrast medium, MRI contrast medium and Fluoroquinolones portfolio, including Iohexol, Ioversol, Iopamidol, Iodixanol, Iopromide, Iomeprol, Gadobenate Dimeglumine, Gadopentetate Dimeglumine, Gadoterate meglumine, Levofloxacin Hemihydrate, Pazufloxacin mesylate. Core product Iohexol has the COS certificate. We have the largest production scale and cover all major range of X-CT non-ionic contrast medium in China.

Starry has state-of-the-art manufacturing facilities conforming to the most stringent international GMP, our plant is, EDQM, JMDA(Japan), ISO14001 certified, and is preparing the inspection by US FDA. Perfect organziation, R&D, production, quality assurance, regulatory support, EHS, cultural, and sales mangaement system make Starry as one of most dynamic top 100 medium enterprises in Zhejiang Province.

Starry’s mission is to become the leading manufacturer in X-CT nonionic contrast medium diagnose drug and fluoroquinolone antibacterials field.

"Focusing on product quality,serving the customer"is our forever principle. We cooperate sincerely with the global pharmaceutical industry and work together in serving human health undertaking!